Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita
- 12 July 2010
- journal article
- review article
- Published by Elsevier
- Vol. 51 (3) , 151-157
- https://doi.org/10.1016/j.jdermsci.2008.04.003
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Single-Nucleotide-Specific siRNA Targeting in a Dominant-Negative Skin ModelJournal of Investigative Dermatology, 2008
- Development of Therapeutic siRNAs for Pachyonychia CongenitaJournal of Investigative Dermatology, 2008
- Interfering with disease: a progress report on siRNA-based therapeuticsNature Reviews Drug Discovery, 2007
- Strategies for silencing human disease using RNA interferenceNature Reviews Genetics, 2007
- Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cellsNature Medicine, 2006
- Knocking down Disease with siRNAsCell, 2006
- Initial sequencing and comparative analysis of the mouse genomeNature, 2002
- Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cellsNature, 2001
- Mutation of a type II keratin gene (K6a) in pachyonychia congenitaNature Genetics, 1995
- Keratin 16 and keratin 17 mutations cause pachyonychia congenitaNature Genetics, 1995